These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein. Inoue T, Osada K, Tagawa M, Ogawa Y, Haga T, Sogame Y, Hashizume T, Watanabe T, Taguchi A, Katsumata T, Yabuki M, Yamaguchi N. Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):156-62. PubMed ID: 22691713 [Abstract] [Full Text] [Related]
8. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice. Manford F, Riffo-Vasquez Y, Spina D, Page CP, Hutt AJ, Moore V, Johansson F, Forbes B. J Pharm Pharmacol; 2008 Oct 01; 60(10):1305-10. PubMed ID: 18812023 [Abstract] [Full Text] [Related]
9. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system. Feng B, Mills JB, Davidson RE, Mireles RJ, Janiszewski JS, Troutman MD, de Morais SM. Drug Metab Dispos; 2008 Feb 01; 36(2):268-75. PubMed ID: 17962372 [Abstract] [Full Text] [Related]
10. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier. Murata M, Tamai I, Kato H, Nagata O, Tsuji A. J Pharmacol Exp Ther; 1999 Jul 01; 290(1):51-7. PubMed ID: 10381759 [Abstract] [Full Text] [Related]
13. Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux. Dai H, Marbach P, Lemaire M, Hayes M, Elmquist WF. J Pharmacol Exp Ther; 2003 Mar 01; 304(3):1085-92. PubMed ID: 12604685 [Abstract] [Full Text] [Related]
14. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats. Sugimoto H, Hirabayashi H, Kimura Y, Furuta A, Amano N, Moriwaki T. Drug Metab Dispos; 2011 Jan 01; 39(1):8-14. PubMed ID: 20962062 [Abstract] [Full Text] [Related]